Trilaciclib

Generic name: Trilaciclib
Brand names: Cosela
Dosage form: intravenous powder for injection (300 mg)
Drug class: Other immunostimulants

Usage of Trilaciclib

Trilaciclib is used to help prevent bone marrow suppression in people receiving chemotherapy with certain medicines to treat small cell lung cancer.

Trilaciclib may also be used for purposes not listed in this medication guide.

Trilaciclib side effects

Get emergency medical help if you have signs of an allergic reaction: hives, itching; difficult breathing; swelling of your eyes, face, lips, tongue, or throat.

Trilaciclib may cause serious side effects. Call your doctor at once if you have:

pain, redness, warmth, itching, swelling, bruising, or skin changes where the medicine was injected;

fever, chills, cough with mucus;

sudden chest pain, wheezing, dry cough, feeling short of breath;

low calcium level--muscle spasms or contractions, numbness or tingly feeling (around your mouth, or in your fingers and toes); or

low potassium level--leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling.

Your trilaciclib treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of trilaciclib may include:

low levels of calcium or potassium;

headache;

breathing problems;

feeling tired; or

abnormal liver function tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Trilaciclib

You should not be treated with trilaciclib if you are allergic to it.

Tell your doctor if you have ever had liver problems.

Trilaciclib may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using trilaciclib and for at least 3 weeks after your last dose. Tell your doctor if you become pregnant.

You should not breastfeed while using trilaciclib and for at least 3 weeks after your last dose.

Relate drugs

How to use Trilaciclib

Usual Adult Dose for Chemotherapy Toxicity:

240 mg/m2 IV over 30-minute completed within 4 hours prior to the start of chemotherapy dayComments: -Interval between doses of this drug on sequential days should not be greater than 28 hours.-For a is missed, discontinue chemotherapy that day and consider resuming both this drug and the chemotherapy on the next scheduled chemotherapy day.-If this drug is discontinued, wait 96 hours from the last dose of this drug before resuming the chemotherapy regimen alone.Use: -To decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan containing regimen for extensive-stage small cell lung cancer

Warnings

Call your doctor at once if you have pain, redness, warmth, itching, swelling, bruising, or skin changes where the medicine was injected.

What other drugs will affect Trilaciclib

Tell your doctor about all your other medicines, especially:

cisplatin;

dalfampridine; or

dofetilide.

This list is not complete. Other drugs may affect trilaciclib, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.